FR2499406B1 - - Google Patents

Info

Publication number
FR2499406B1
FR2499406B1 FR8202136A FR8202136A FR2499406B1 FR 2499406 B1 FR2499406 B1 FR 2499406B1 FR 8202136 A FR8202136 A FR 8202136A FR 8202136 A FR8202136 A FR 8202136A FR 2499406 B1 FR2499406 B1 FR 2499406B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8202136A
Other languages
French (fr)
Other versions
FR2499406A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of FR2499406A1 publication Critical patent/FR2499406A1/fr
Application granted granted Critical
Publication of FR2499406B1 publication Critical patent/FR2499406B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FR8202136A 1981-02-10 1982-02-10 Medicaments a base de nouveaux derives de la furo-(3,4-c)-pyridine Granted FR2499406A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8104072 1981-02-10

Publications (2)

Publication Number Publication Date
FR2499406A1 FR2499406A1 (fr) 1982-08-13
FR2499406B1 true FR2499406B1 (US07754267-20100713-C00017.png) 1984-03-30

Family

ID=10519587

Family Applications (2)

Application Number Title Priority Date Filing Date
FR8202137A Granted FR2499574A1 (fr) 1981-02-10 1982-02-10 Nouveaux derives de la furo-(3,4-c)-pyridine et leur preparation
FR8202136A Granted FR2499406A1 (fr) 1981-02-10 1982-02-10 Medicaments a base de nouveaux derives de la furo-(3,4-c)-pyridine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR8202137A Granted FR2499574A1 (fr) 1981-02-10 1982-02-10 Nouveaux derives de la furo-(3,4-c)-pyridine et leur preparation

Country Status (34)

Country Link
US (1) US4383998A (US07754267-20100713-C00017.png)
JP (1) JPS57150688A (US07754267-20100713-C00017.png)
KR (1) KR870000206B1 (US07754267-20100713-C00017.png)
AR (1) AR230284A1 (US07754267-20100713-C00017.png)
AU (1) AU545876B2 (US07754267-20100713-C00017.png)
BE (1) BE891797A (US07754267-20100713-C00017.png)
CA (1) CA1175837A (US07754267-20100713-C00017.png)
CH (1) CH649554A5 (US07754267-20100713-C00017.png)
DE (1) DE3204596A1 (US07754267-20100713-C00017.png)
DK (1) DK157551C (US07754267-20100713-C00017.png)
DZ (1) DZ376A1 (US07754267-20100713-C00017.png)
ES (1) ES8302714A1 (US07754267-20100713-C00017.png)
FI (1) FI75347C (US07754267-20100713-C00017.png)
FR (2) FR2499574A1 (US07754267-20100713-C00017.png)
GB (1) GB2092586B (US07754267-20100713-C00017.png)
GR (1) GR75905B (US07754267-20100713-C00017.png)
HK (1) HK22485A (US07754267-20100713-C00017.png)
HU (1) HU185088B (US07754267-20100713-C00017.png)
IE (1) IE52376B1 (US07754267-20100713-C00017.png)
IL (1) IL64759A (US07754267-20100713-C00017.png)
IN (1) IN156817B (US07754267-20100713-C00017.png)
IT (1) IT1157252B (US07754267-20100713-C00017.png)
LU (1) LU83886A1 (US07754267-20100713-C00017.png)
MA (1) MA19378A1 (US07754267-20100713-C00017.png)
MX (1) MX6983E (US07754267-20100713-C00017.png)
NL (1) NL186697C (US07754267-20100713-C00017.png)
NO (1) NO156373C (US07754267-20100713-C00017.png)
NZ (1) NZ199528A (US07754267-20100713-C00017.png)
OA (1) OA07003A (US07754267-20100713-C00017.png)
PT (1) PT74408B (US07754267-20100713-C00017.png)
SE (1) SE456994B (US07754267-20100713-C00017.png)
SG (1) SG85384G (US07754267-20100713-C00017.png)
YU (1) YU44000B (US07754267-20100713-C00017.png)
ZA (1) ZA82158B (US07754267-20100713-C00017.png)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
IN160104B (US07754267-20100713-C00017.png) * 1983-04-05 1987-06-27 Scras
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
GB0221494D0 (en) * 2002-09-16 2002-10-23 Generics Uk Ltd Novel processes for the preparation of 1.3-dihydro-6-methylfuro (3,4-c) pyndin derivatives
HUP0300990A2 (hu) * 2003-04-15 2005-05-30 SynoSens Kutató és Fejlesztő Kft. Szinergista gyógyszer-kombináció a diabetesz megelőzésére vagy kezelésére
WO2005009446A1 (en) * 2003-07-17 2005-02-03 Cotherix, Inc. Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20060153934A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and magnesium
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
EP1804795A4 (en) * 2004-09-22 2007-11-07 Cornett Glen ENANTIOMERIC COMPOSITIONS OF CICLETANINE, ALONE OR COMBINED WITH OTHER AGENTS, USED FOR THERAPEUTIC PURPOSES
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
JP2010514841A (ja) * 2007-01-03 2010-05-06 グレン ブイ. コルネット, 肺疾患および心疾患の処置におけるシクレタニンおよびpkc阻害剤
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
US8214941B2 (en) 2008-10-02 2012-07-10 Kohler Co. Slip-fit clamping system for mounting a fitting on a wall
WO2011043914A1 (en) * 2009-10-09 2011-04-14 Merck Sharp & Dohme Corp. Diuretics
US8354394B2 (en) 2009-10-29 2013-01-15 Merck Sharp & Dohme Corp. Diuretics
WO2015103445A1 (en) * 2013-12-31 2015-07-09 Rockey Don C Systems, methods, techniques, and compounds in research and treatment of portal hypertension and other conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use

Also Published As

Publication number Publication date
GR75905B (US07754267-20100713-C00017.png) 1984-08-02
MA19378A1 (fr) 1982-10-01
IN156817B (US07754267-20100713-C00017.png) 1985-11-09
ES509449A0 (es) 1983-01-16
NO820253L (no) 1982-08-11
OA07003A (fr) 1983-08-31
DK157551C (da) 1990-06-11
DE3204596A1 (de) 1982-09-09
IT8219502A0 (it) 1982-02-08
PT74408A (en) 1982-03-01
IL64759A (en) 1985-09-29
AR230284A1 (es) 1984-03-01
HK22485A (en) 1985-03-29
IE820288L (en) 1982-08-10
GB2092586B (en) 1984-09-26
FR2499574B1 (US07754267-20100713-C00017.png) 1984-03-30
LU83886A1 (fr) 1982-06-30
US4383998A (en) 1983-05-17
DZ376A1 (fr) 2004-09-13
BE891797A (fr) 1982-04-30
FI75347B (fi) 1988-02-29
JPS57150688A (en) 1982-09-17
HU185088B (en) 1984-11-28
PT74408B (en) 1983-07-07
ES8302714A1 (es) 1983-01-16
SE8200744L (sv) 1982-08-11
NZ199528A (en) 1984-02-03
SE456994B (sv) 1988-11-21
JPH0261477B2 (US07754267-20100713-C00017.png) 1990-12-20
AU8029482A (en) 1982-08-19
KR870000206B1 (ko) 1987-02-16
YU44000B (en) 1990-02-28
YU25382A (en) 1984-08-31
ZA82158B (en) 1982-11-24
IE52376B1 (en) 1987-09-30
NO156373C (no) 1987-09-09
CH649554A5 (fr) 1985-05-31
IL64759A0 (en) 1982-03-31
NO156373B (no) 1987-06-01
AU545876B2 (en) 1985-08-01
DE3204596C2 (US07754267-20100713-C00017.png) 1991-07-04
NL186697B (nl) 1990-09-03
MX6983E (es) 1987-01-19
FR2499574A1 (fr) 1982-08-13
DK54382A (da) 1982-08-11
NL186697C (nl) 1991-02-01
FI75347C (fi) 1988-06-09
IT1157252B (it) 1987-02-11
CA1175837A (en) 1984-10-09
GB2092586A (en) 1982-08-18
SG85384G (en) 1985-06-07
FR2499406A1 (fr) 1982-08-13
DK157551B (da) 1990-01-22
KR830009106A (ko) 1983-12-17
FI820353L (fi) 1982-08-11
NL8200180A (nl) 1982-09-01

Similar Documents

Publication Publication Date Title
FR2498494B1 (US07754267-20100713-C00017.png)
FR2501380B1 (US07754267-20100713-C00017.png)
FR2497975B1 (US07754267-20100713-C00017.png)
FR2503310B3 (US07754267-20100713-C00017.png)
FR2501436B1 (US07754267-20100713-C00017.png)
FR2501840B1 (US07754267-20100713-C00017.png)
FR2501645B1 (US07754267-20100713-C00017.png)
CH665743GA3 (US07754267-20100713-C00017.png)
FR2500406B1 (US07754267-20100713-C00017.png)
FR2499466B1 (US07754267-20100713-C00017.png)
FR2502622B1 (US07754267-20100713-C00017.png)
FR2502676B3 (US07754267-20100713-C00017.png)
DE3280382D1 (US07754267-20100713-C00017.png)
FR2498373B1 (US07754267-20100713-C00017.png)
FR2504789B3 (US07754267-20100713-C00017.png)
FR2504265B1 (US07754267-20100713-C00017.png)
FR2498597B1 (US07754267-20100713-C00017.png)
FR2502921B1 (US07754267-20100713-C00017.png)
FR2500966B1 (US07754267-20100713-C00017.png)
FR2500613B3 (US07754267-20100713-C00017.png)
FR2500999B1 (US07754267-20100713-C00017.png)
FR2502212B3 (US07754267-20100713-C00017.png)
FR2503587B1 (US07754267-20100713-C00017.png)
FR2502660B1 (US07754267-20100713-C00017.png)
FR2499428B3 (US07754267-20100713-C00017.png)

Legal Events

Date Code Title Description
CL Concession to grant licences
ST Notification of lapse